Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0122
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 0409-0122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Daptomycin 02)
Principal Display Panel (500 mg Vial Label)
This appears to be a description of a pharmaceutical product. The package contains a single dose vial of Daptomycin for injection, which must be reconstituted with 10L of sodium chloride injection. The package includes dosage and storage information, and should be kept at a temperature of 2°C to 25°C (36°F to 77°F). The barcode provided is for human readable information and the package should be used for intravenous use only. The product is distributed by Hospira Inc. and includes a lot number (S014321AA) and expiration date (YYYYMMMDD).*
Principal Display Panel (500 mg Vial Carton)
Principal Display Panel (350 mg Vial Label)
This is a product label for an injection containing 350 mg per vial of Daptomycin. The barcode included is 0100304090120014. The package insert may contain additional dosage information for intravenous use. The product is distributed by Hospira Inc. located in Lake Forest, IL, USA. The lot number is S014321AA and the expiration date is not given. The injection should be stored at a temperature between 2°C to 25°C and should not be frozen, as noted by the USP guidelines.*
Principal Display Panel (350 mg Vial Carton)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.